Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018)

Amarin Corp Plcuk (AMRN) reported Receivables - Other of $25.7 million for Q3 2018, up 7208.83% quarter-over-quarter from $351000.0 in Q4 2010.

Amarin Corp Plcuk (AMRN) Receivables - Other (2010 - 2018) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 2 years of Receivables - Other data on file, last reported at $25.7 million in Q3 2018.

Receivables - Other for Q3 2018 came in at $25.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2018 was $25.7 million (changed N/A YoY), and the FY2010 annual result was $351000.0, changed N/A from the prior year.
Receivables - Other climbed to $25.7 million in Q3 2018 per AMRN's latest filing, from $351000.0 in the prior quarter.
Over five years, Receivables - Other peaked at $25.7 million in Q3 2018 and troughed at $25.7 million in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn
10	Amarin Corp Plcuk	5.84 Bn	5.66 Bn	17.77 Mn

Download Data